Writing Group Disclosures

Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers’ Bureau/ HonorariaExpert WitnessOwnership InterestConsultant/ Advisory BoardOther
Alan S. GoKaiser Permanente Northern CaliforniaNIHNoneNoneNoneNoneNoneNone
Mary Ann BaumanINTEGRIS Health, IncNoneNoneNoneNoneNoneNoneNone
Sallyann M. Coleman KingCDCNoneNoneNoneNoneNoneNoneNone
Gregg C. FonarowUCLAAHRQ; NIHNoneNoneNoneNoneNovartis; Bayer*; Johnson & Johnson*; Medtronic*None
Willie LawrenceHCA and Midwest Heart and Vascular AssociatesNoNoNoNoNoBCBS KC (Credentials Committee, P & T Committee)*Wife is CFO Childrens’ Mercy Hospital, KC
Eduardo SanchezAmerican Heart Association (since April 15, 2013); Blue Cross and Blue Shield of Texas (through April 15, 2013)NoneNoneNoneNoneNoneNoneNone
Kim A. WilliamsRush UniversityNoneNoneNoneNoneNoneNoneNone
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Modest.

  • Significant.